Émilia Liana Falcone

Émilia Liana Falcone

Fondation de l'Institut de recherches cliniques de Montréal (IRCM)

Researcher

Biography

Dr. Emilia Liana Falcone leads the IRCM Post-COVID-19 (IPCO) Research Clinic and the Microbiome and Mucosal Defenses Research Unit at the Montreal Clinical Research Institute (IRCM). She is also an Assistant Research Professor at the IRCM and an Assistant Clinical Professor in the Department of Medicine at the Université de Montréal. As the Canada Research Chair on the role of the microbiome in primary immunodeficiency, Dr. Falcone focuses her work on two main areas: post-COVID-19 conditions and the study of the microbiome and mucosal defenses.

Research and impacts

  • Recognized media voice: over 110 media appearances (print, digital, broadcast, podcasts) as an expert on the microbiota, immune dysregulation, and long COVID.
  • Significant discovery: her research on the microbiota-metabolome in CTLA-4 deficiency was highlighted by the Université de Montréal and the IRCM in 2025 for the identification of biomarkers.
  • International recognition: cited by the journal *Science* for her work linking the microbiota to long COVID, as well as for her pioneering research clinic dedicated to long COVID.

Researchers